May 22, 2024
Cipla receives final approval for the generic version of Somatuline® Depot (Lanreotide) Injection 120 mg/ 0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL
Jan 08, 2024
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products
Jan 12, 2021
Cipla to Present at the 39th Annual J.P. Morgan Healthcare Conference
Nov 18, 2020
Cipla launches 'Covi-G' for COVID-19 rapid antibody detection
Sep 28, 2020
Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera® (Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pack)
Aug 21, 2020
Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
May 19, 2020
Cipla Files ANDA for Generic Version of GSK's Advair Diskus®
Apr 22, 2020
Global OTC Drugs Market to Reach $237.6 Billion by 2027 - Key Opportunities, Challenges and Recommendations
Apr 21, 2020
Asia-Pacific Respiratory Drug Markets 2020 Featuring Profiles of Air Liquide, Aradigm, AstraZeneca, Baxter, Boehringer Ingelheim, Cipla, Roche, GlaxoSmithKline, and More
Apr 21, 2020
Global Pharmaceutical Manufacturing Market is Expected to Grow at a CAGR of 7.0% During 2018-2027
Apr 17, 2020
Asia-Pacific Respiratory Device Industry Insights, 2019-2025 - Key Players are ResMed, Cipla, GlaxoSmithKline, 3M, Novartis, and Omron Healthcare
Apr 09, 2020
Cipla Receives Final Approval for Generic Version of Proventil® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (Base)/Actuation)
Mar 27, 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Mar 26, 2020
Pulmatrix Reports 2019 Financial Results and Provides Business Update
Feb 10, 2020
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries
Nov 29, 2019
Global Doxorubicin Market Analysis and Forecast 2019-2024 - Key Players are Cadila Pharmaceuticals, Cipla, Pfizer, Johnson & Johnson
Nov 01, 2019
Pulmatrix Reports Q3 2019 Results
Sep 26, 2019
Cipla Announces the Launch of Daptomycin for Injection, 500 mg/vial, Single-dose Vials (for Intravenous use only)
Aug 05, 2019
Pulmatrix Reports Q2 2019 Results
Jul 29, 2019
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets